Hysteroscopic treatment of uterine fibroids using vaporization
Official title: Evaluation of a Hysteroscopic Method With Vaporization in the Hysteroscopic Treatment of Submucosal Uterine Fibroids
Run by Assistance Publique Hopitaux De Marseille · NCT05078307 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new way to treat uterine fibroids using vaporization to see if it can make the procedure quicker compared to the traditional method for women over 18.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 54 (estimated) |
| Sponsor | Assistance Publique Hopitaux De Marseille Academic / other |
| Locations | 1 site (Marseille, Bouches-du-Rhone) |
| Trial ID | NCT05078307 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18 and older with diagnosed submucosal uterine fibroids less than 6 cm requiring operative hysteroscopy.
✕Probably not a fit
Patients who are minors, pregnant, or unable to provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates a new hysteroscopic technique for treating submucosal uterine fibroids, comparing the traditional resection method with a vaporization approach. It aims to determine if the vaporization technique can reduce the operative time required for the procedure. Women over 18 years old with confirmed uterine fibroids will be randomly assigned to either the vaporization or resection group after providing informed consent. The study is conducted at a single center in Marseille.
Why it matters
Potential benefit: If successful, this technique could lead to shorter surgery times and potentially improved outcomes for women undergoing treatment for uterine fibroids.
How similar studies have gone: There are few comparative studies on this technique, indicating that while it is a novel approach, its effectiveness is not yet well-established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient at least 18 years old. * Non-pregnant patient * A patient who had an ultrasound confirming the presence of a uterine fibroid to be treated less than 6 cm. * Patient who had a diagnostic hysteroscopy confirming the presence of a uterine fibroid to be treated of type 0, 1 or 2 according to the FIGO classification. * Patient presenting an indication for intra uterine fibroid resection (bleeding, fertility problems) by operative hysteroscopy. * Patient having agreed to participate in the study and having signed an informed consent. Exclusion Criteria: * Minor patient * Patient not affiliated to a social security system * Persons benefiting from special protection: by virtue of articles L1121-5 to L1121-8 of the Public Health Code: pregnant or breast-feeding women, minors, adults under guardianship or curatorship, persons deprived of liberty. * Patient refusing to sign the consent or unable to receive the information necessary to give informed consent.
Where it's running
-
Assistance Publique Hôpitaux Marseille
Marseille, Bouches-du-Rhone, France Recruiting
Study contacts
- Study coordinator: Aubert Agostini, MD/PhD
- Email: aubert.agostini@ap-hm.fr
- Phone: 04 91 38 37 87
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predictors of Success and Failure of v-NOTES Hysterectomy for Large Uteri
This study looks at which factors predict whether a v-NOTES hysterectomy for large uteri will be completed without needing to switch to another surgical approach.
-
KLH-2109 for heavy menstrual bleeding from uterine fibroids
We are testing whether KLH-2109 can reduce heavy menstrual bleeding in people with uterine fibroids.
-
Elix Cycle Balance and Elix Daily Harmony for fibroid-related symptoms
This 24-week virtual study will test whether taking the herbal supplements Elix Cycle Balance and Elix Daily Harmony daily can reduce menstrual pain and other fibroid-related symptoms in women aged 20–45 with uterine fibroids.
-
Relugolix treatment for heavy menstrual bleeding from uterine fibroids
This trial will test whether taking relugolix 40 mg once daily can reduce heavy menstrual bleeding in premenopausal women with uterine fibroids compared with placebo.
-
Evaluating bone health in women with uterine fibroids or endometriosis using a medication
This study is testing if a new medication can help improve bone health in women with uterine fibroids or endometriosis who have heavy bleeding or pain.
-
Combination of natural supplements for treating uterine fibroids
This study is testing a mix of natural supplements to see if they can reduce the size of larger uterine fibroids in women who have them.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.